Ignite Creation Date:
2025-12-25 @ 3:44 AM
Ignite Modification Date:
2025-12-26 @ 2:30 AM
Study NCT ID:
NCT03518502
Status:
UNKNOWN
Last Update Posted:
2018-05-08
First Post:
2018-04-21
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Sorafenib Monotherapy vs. TACE-sorafenib Sequential Therapy for HCC With Metastasis
Sponsor:
Korea University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-03-01
Start Date Type:
ACTUAL
Primary Completion Date:
2020-02-28
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-02-28
Completion Date Type:
ESTIMATED
First Submit Date:
2018-04-21
First Submit QC Date:
None
Study First Post Date:
2018-05-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-05-06
Last Update Post Date:
2018-05-08
Last Update Post Date Type:
ACTUAL